Drugs / SUN11031
last change Oct 2009 re-read 3 minutes ago

SUN11031

Developed for
hypoproteinemia, hypercatabolic
Investigated by
Daiichi Sankyo

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00698828 May 2008 → Oct 2009 hypoproteinemia, hypercatabolic Daiichi Sankyo Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SUN11031 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00698828 ↗
Route Subcutaneous “subcutaneous injections” NCT00698828 ↗